Jack completed his PhD in medical genetics at the University of British Columbia with Prof Elizabeth Simpson studying AAV gene therapy for aniridia. In 2018 he crossed the Atlantic to do a postdoc working on lentiviral gene therapy for alpha-1 antitrypsin deficiency with Profs Eric Alton and Uta Griesenbach at Imperial College London. Joining the Morshead lab in Autumn 2022, Jack is bringing his gene therapy expertise to study astrocyte to neuron reprogramming and how it could be used to treat stroke.